Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) — Cash Flow Reinvestment Rate
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) has a Cash Flow Reinvestment Rate of 1.10x as of December 2023, reinvesting CN¥9.28 Million (capex CN¥4.72 Million plus investments CN¥-4.56 Million) from operating cash flow of CN¥8.45 Million. Check Hangzhou TianMuShan Pharmaceutical Enter (600671) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Cash Flow Reinvestment Rate (1998–2025)
Historical reinvestment intensity for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd across 17 annual periods. Explore Hangzhou TianMuShan Pharmaceutical Enter (600671) long-term investment share to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (1998–2025)
Year-by-year capital reinvestment analysis for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. For live market cap and broader valuation context, see Hangzhou TianMuShan Pharmaceutical Enter stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.64x | CN¥31.18 Million | CN¥11.79 Million | CN¥31.18 Million | ▲ +175.8% |
| 2019 | 0.96x | CN¥154.50 Million | CN¥161.13 Million | CN¥94.66 Million | ▼ -30.3% |
| 2018 | 1.38x | CN¥97.30 Million | CN¥70.71 Million | CN¥37.46 Million | ▼ -51.6% |
| 2017 | 2.84x | CN¥69.76 Million | CN¥24.52 Million | CN¥62.25 Million | ▼ -86.0% |
| 2016 | 20.36x | CN¥32.72 Million | CN¥1.61 Million | CN¥25.21 Million | ▼ -56.3% |
| 2014 | 46.59x | CN¥30.46 Million | CN¥653.79K | CN¥30.46 Million | ▲ +4864.1% |
| 2013 | 0.94x | CN¥11.61 Million | CN¥12.37 Million | CN¥11.61 Million | ▼ -75.2% |
| 2009 | 3.79x | CN¥28.74 Million | CN¥7.58 Million | CN¥28.74 Million | ▲ +381.2% |
| 2008 | 0.79x | CN¥16.69 Million | CN¥21.19 Million | CN¥16.69 Million | ▼ -55.3% |
| 2007 | 1.76x | CN¥83.83 Million | CN¥47.53 Million | CN¥83.83 Million | ▲ +602.5% |
| 2006 | 0.25x | CN¥13.90 Million | CN¥55.39 Million | CN¥13.90 Million | ▼ -81.5% |
| 2005 | 1.36x | CN¥11.54 Million | CN¥8.48 Million | CN¥11.54 Million | ▼ -78.1% |
| 2004 | 6.22x | CN¥8.42 Million | CN¥1.35 Million | CN¥8.42 Million | ▲ +657.4% |
| 2002 | 0.82x | CN¥17.90 Million | CN¥21.80 Million | CN¥17.90 Million | ▼ -3.7% |
| 2001 | 0.85x | CN¥8.97 Million | CN¥10.52 Million | CN¥8.97 Million | ▲ +138.9% |
| 1999 | 0.36x | CN¥17.53 Million | CN¥49.09 Million | CN¥17.53 Million | ▼ -95.6% |
| 1998 | 8.11x | CN¥19.10 Million | CN¥2.36 Million | CN¥19.10 Million | — |